Senofilcon A lenses may help reduce contact discomfort

Article

Jacksonville, FL?A new study shows that soft contact lenses made with senofilcon A, a new-generation silicone hydrogel material, were associated with a reduction in discomfort, dryness, and other commonly reported problems associated with contact lens wear. Contact lenses made with senofilcon A are currently marketed in the United States under the name Acuvue Oasys Brand Contact Lenses with Hydraclear Plus.

Jacksonville, FL-A new study shows that soft contact lenses made with senofilcon A, a new-generation silicone hydrogel material, were associated with a reduction in discomfort, dryness, and other commonly reported problems associated with contact lens wear. Contact lenses made with senofilcon A are currently marketed in the United States under the name Acuvue Oasys Brand Contact Lenses with Hydraclear Plus.

Problems with discomfort and dryness affect approximately 67% of the more than 36 million contact lens wearers in the United States, with about four in 10 (42%) wearers reporting that they use rewetting drops at least once a day to keep their eyes from feeling dry. And, while 3 million people a year become new contact lens wearers, studies suggest that during the same period approximately 2.7 million people stop wearing contact lenses, with one in four (24%) citing dry, challenging environments or wearing conditions as reasons for discontinuing contact lens wear.

The study was sponsored by Vistakon, a division of Johnson & Johnson Vision Care Inc., marketer of Acuvue Oasys.

Recent Videos
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
© 2024 MJH Life Sciences

All rights reserved.